Betrixaban is a broad anti-virus inhibitor by activating innate immunity
The innate immune system serves as the first line of defense against viral infections. Type I interferon (IFN-I) signaling, in particular, plays a crucial role in mediating antiviral immunity. Here, we identify Betrixaban (BT), a novel small-molecule compound that activates innate immune responses,...
Saved in:
| Main Authors: | Shiyu Hu, Yang Zhao, Xingyu Chen, Haocheng Wang, Wenjun Hu, Rong Huang, Jian Yang, Chenxi Niu, Xuefei Guo, Fuping You |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1603530/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nuclear shuttling of CDC4 mediated broad-spectrum antiviral activity against diverse coronaviruses
by: Mingwei Li, et al.
Published: (2025-12-01) -
Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses
by: Elisa Feyles, et al.
Published: (2025-06-01) -
Broad-spectrum coronavirus inhibitors discovered by modeling viral fusion dynamics
by: Charles B. Reilly, et al.
Published: (2025-05-01) -
Inositol metabolism as a broad-spectrum antiviral target
by: Kunlakanya Jitobaom, et al.
Published: (2025-08-01) -
Exploiting the Achilles’ Heel of Viral RNA Processing to Develop Novel Antivirals
by: Ali Zahedi Amiri, et al.
Published: (2024-12-01)